ANGIOLINE SUPPORTED THE IX ANNUAL INTERNATIONAL CONFERENCE ON HYBRID TECHNOLOGIES IN THE TREATMENT OF CARDIOVASCULAR DISEASES

Angioline sponsored the IX Annual International Conference on Hybrid Technologies in the Treatment of Cardiovascular Diseases, one of the most authoritative medical events in Russia for specialists in cardiosurgery. The conference was held in Moscow on February 4-6, 2018 at the Federal State Budgetary Institution National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation.

Within the framework of the exhibition of medical manufacturers, linked to the conference, Angioline presented a line of new products. In particular, the samples of the transcatheter aortic heart valve, the stent graft, the retrieval system for thrombus extraction, the venous implant of the cava filter and the cardiac implant of the left atrial appendage closure device were available to visitors of its stand.
All products are in different stages of market launch and, with the exception of the cava filter, have no analogues at the Russian market.